Global Meningococcal Vaccines Market Size study, by Vaccine Serotype (MenACWY, MenB & Manic, MenC, MenA, MenAC), by Vaccine Type (Conjugate, Polysaccharide, Subcapsular), by End User (Pediatric, Adult, Travelers) and Regional Forecasts 2022-2032

Global Meningococcal Vaccines Market Size study, by Vaccine Serotype (MenACWY, MenB & Manic, MenC, MenA, MenAC), by Vaccine Type (Conjugate, Polysaccharide, Subcapsular), by End User (Pediatric, Adult, Travelers) and Regional Forecasts 2022-2032

Global Meningococcal Vaccines Market is valued approximately at USD 3.48 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 6.0% over the forecast period 2024-2032. Invasive meningococcal disease (IMD), caused by Neisseria meningitidis, encompasses severe infections like meningitis and bacteremia, which, if untreated, can result in a fatality rate as high as 50%. This disease primarily affects the brain and spinal cord linings and has the potential to cause large-scale epidemics. Transmission occurs through direct contact with respiratory or throat secretions from infected individuals or asymptomatic carriers. Out of the 12 serogroups of N. meningitidis, serogroups A, B, C, W, and Y are the major culprits responsible for the majority of global cases. The unpredictable circulation of these serogroups across different age groups and regions necessitates the availability of vaccines targeting each serogroup.

The market for meningococcal vaccines is poised for significant growth, driven by increasing adoption in national immunization programs across various countries and a rise in meningococcal outbreaks globally. These outbreaks have escalated the demand for effective vaccines, thereby propelling market growth. However, stringent regulatory frameworks for new vaccine approvals and product recalls due to contamination issues pose challenges to market expansion. On a positive note, ongoing research and development in meningococcal vaccines and rising global healthcare expenditure present lucrative growth opportunities for the market.

North America led the market in 2023, holding a revenue share of 53%, followed by Europe. The dominance of North America is attributed to favorable governmental recommendations, substantial R&D investments, a robust healthcare infrastructure, and extensive awareness campaigns. In contrast, the Asia Pacific region is anticipated to witness rapid growth during the forecast period. Factors such as a growing pediatric population and proactive government initiatives to combat the increasing prevalence of the disease contribute to this growth. Non-profit organizations in the region also play a crucial role in spreading awareness among the public and healthcare professionals, further boosting vaccine adoption.

Major market players included in this report are:

GlaxoSmithKline plc

Pfizer Inc.

Sanofi Pasteur

Merck & Co., Inc.

Novartis AG

CSL Limited

Johnson & Johnson

Bharat Biotech International Limited

Serum Institute of India Pvt. Ltd.

Sinovac Biotech Ltd.

Biological E Limited

Chongqing Zhifei Biological Products Co., Ltd.

Beijing Tiantan Biological Products Co., Ltd.

Hualan Biological Engineering Inc.

Walvax Biotechnology Co., Ltd.

The detailed segments and sub-segment of the market are explained below:

By Vaccine Serotype:
• MenACWY
• MenB & Manic
• MenC
• MenA
• MenAC

By Vaccine Type:
• Conjugate
• Polysaccharide
• Subcapsular

By End User:
• Pediatric
• Adult
• Travelers

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC

Latin America
• Brazil
• Mexico
• RoLA

Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA

Years considered for the study are as follows:
• Historical year – 2022
• Base year – 2023
• Forecast period – 2024 to 2032

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.